SPINK5
protein-codingserine peptidase inhibitor Kazal type 5, the group of Serine peptidase inhibitors, Kazal type
Gene summary
This gene encodes a multidomain serine protease inhibitor that contains 15 potential inhibitory domains. The encoded preproprotein is proteolytically processed to generate multiple protein products, which may exhibit unique activities and specificities. These proteins may play a role in skin and hair morphogenesis, as well as anti-inflammatory and antimicrobial protection of mucous epithelia. Mutations in this gene may result in Netherton syndrome, a disorder characterized by ichthyosis, defective cornification, and atopy. This gene is present in a gene cluster on chromosome 5. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~111.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009735
Submitter: ClinGen
Biallelic SPINK5 germline loss-of-function variants were first identified in families with Netherton syndrome (NS) in 2000 (PMID: 10835624). SPINK5 deficiency is associated with a classic clinical triad of congenital ichthyosiform erythroderma, trichorrhexis invaginata (bamboo hair), and severe atopic manifestations. Clinical defects are multisystemic and frequently include life-threatening hypernatremic dehydration in the neonatal period, failure to thrive, severe skin inflammation, enteropathy, and markedly elevated serum IgE levels accompanied by hypereosinophilia and severe allergies. Most curated pathogenic variants are nonsense, frameshift, or splice-site variants predicted to result in loss of function. Multiple unique variants from individuals across multiple publications have been curated (PMID: 11511292, 37102386, 41611084, 24577329). Heterozygous carriers of pathogenic SPINK5 loss-of-function variants do not develop Netherton syndrome. More evidence is available in the literature, but the maximum score for genetic evidence has been reached (12 pts). Studies examining SPINK5 function utilize patient-derived cells and skin biopsy tissues to support this gene-disease relationship. SPINK5 encodes the lympho-epithelial Kazal-type-related inhibitor (LEKTI), a multidomain serine protease inhibitor primarily expressed in the outer granular layer of stratified epithelial tissues. In healthy skin, LEKTI inhibits the activity of epidermal serine proteases, such as kallikreins KLK5, KLK7, and KLK14, which are essential for physiological desquamation and epidermal remodeling (PMID: 17596512). LEKTI has been shown to be expressed in healthy human epidermis but is absent in patients harboring bi-allelic pathogenic SPINK5 variants (PMID:12915442). In vitro functional data demonstrates that this deficiency causes increased epidermal protease hyperactivity, which leads to the premature cleavage of desmosomes, specifically via the rapid degradation of desmoglein (PMID:17989726, 16628198). Mouse models of SPINK5 deficiency replicate the key clinical features of human Netherton syndrome. These animals exhibit altered desquamation, impaired keratinization, hair malformations, severe skin barrier defects, and high postnatal mortality due to dehydration and skin-barrier failure (PMID: 15619623, 38316920). In summary, SPINK5 is definitively associated with autosomal recessive Netherton syndrome. This association is supported by extensive human genetic evidence, functional studies in patient-derived tissues and cells, biochemical data demonstrating LEKTI-dependent inhibition of epidermal kallikreins, and mouse models recapitulating key features of the human disease. This association has been repeatedly demonstrated in both research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen SCID-CID Working Group on 5/21/2026 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0009735
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009735
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009735
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0009735
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009735
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Dermatologic
Intervention: Allergy/Immunology/Infectious; Dermatologic
Rationale: The condition may not always be readily recognizable; Recurrent bacterial infections are common, and prophylactic measures, as well as prompt and aggressive treatment of infections may be beneficial; Hypernatremic dehydration in the neonatal period can result in severe sequelae, and awareness may allow preventive measures and prompt medical management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SPINK5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006846.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 11 | 161 | 2 | 175 | |
| missense | 2 | 379 | 28 | 4 | 413 | |
| nonsense | 29 | 7 | 1 | 37 | ||
| start loss | 1 | 1 | ||||
| frameshift | 37 | 14 | 51 | |||
| splice donor/acceptor (+/-2bp) | 12 | 22 | 2 | 1 | 37 | |
| Total | 78 | 46 | 394 | 190 | 6 | 714 |
Highest pathogenic variant AF is 0.0002083032
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006837.2 | 33 | MANE Select | |
| Ensembl | ENSP00000256084.7 | 33 | MANE Select | |
| RefSeq | NP_001121170.1 | 34 | Standard | |
| RefSeq | NP_001121171.1 | 28 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Keratinization
- Developmental Biology
- Formation of the cornified envelope
Biological Process
- negative regulation of antibacterial peptide production
- epidermal cell differentiation
- negative regulation of angiogenesis
- regulation of cell adhesion
- extracellular matrix organization
Molecular Function
- serine-type endopeptidase inhibitor activity
Cellular Component
- extracellular region
- cytoplasm
- endoplasmic reticulum
- endoplasmic reticulum membrane
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000359874
- Coding exons
- 34
- Length
- 111607
- Individuals with no LoFs
- 124681
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 125
- Defined
- 124807
- p
- 0.000505
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.278 | 562 | 581 | 0.967 | 0.0000310 | 7326 |
| Missense (PolyPhen) | 201 | 208.61 | 0.96353 | 2674 | ||
| Synonymous | -0.326 | 185 | 179 | 1.03 | 0.00000908 | 1825 |
| Loss of Function | 2.04 | 53 | 71.7 | 0.740 | 0.00000410 | 896 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00058 | 0.00058 | rare |
| Latino/Admixed American | 0.00038 | 0.00038 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.0016 | 0.0016 | notable |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00046 | 0.00046 | rare |
| South Asian | 0.00036 | 0.00036 | rare |
| Other | 0.0010 | 0.00082 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Serine protease inhibitor, probably important for the anti-inflammatory and/or antimicrobial protection of mucous epithelia. Contribute to the integrity and protective barrier function of the skin by regulating the activity of defense- activating and desquamation-involved proteases. Inhibits KLK5, it's major target, in a pH-dependent manner. Inhibits KLK7, KLK14 CASP14, and trypsin. {ECO:0000269|PubMed:10419450, ECO:0000269|PubMed:17596512, ECO:0000269|PubMed:20533828}.;
- Disease
- DISEASE: Netherton syndrome (NETH) [MIM:256500]: An autosomal recessive congenital ichthyosis associated with hair shaft abnormalities and anomalies of the immune system. Typical features are ichthyosis linearis circumflexa, ichthyosiform erythroderma, trichorrhexis invaginata (bamboo hair), atopic dermatitis, and hayfever. High postnatal mortality is due to failure to thrive, infections and hypernatremic dehydration. {ECO:0000269|PubMed:10835624}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.293
Intolerance Scores
- LoFtool
- 0.997
- RVIS EVS
- 2.83
- RVIS percentile EVS
- 99.09
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0356
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | High | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |